title: [Failure to thrive and dyslipidemia caused by citrin deficiency: a novel clinical phenotype].
abstract: Two clinical phenotypes for citrin deficiency (CD) have been reported. One is adult-onset citrullinemia type II (CTLN2) and another is neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). A child with CD and who had failure to thrive (FTT) and dyslipidemia as main clinical manifestations is reported here. Both the weight-and length-for-age at 18 months dropped below the 3rd percentile in the corresponding WHO anthropometry percentile charts, while blood biochemical analysis revealed dramatically increased triglyceride and total cholesterol, together with reduced HDL-cholesterol. Inquiries revealed his aversion to rice and fondness for fish since the age of one year, a peculiar habit which could not be corrected. Since the age of two years, the peculiar diet became more obvious, and slightly increased citrulline and threonine levels were detected on blood amino acid analysis. At the age of two years and five months he was suspected to have CD. Since then, he has been fed in accordance with his own food preferences, and FTT improved gradually, with weight-for-age, in particular, recovering beyond the 3rd percentile at three years of age, and dyslipidemia was also ameliorated gradually. SLC25A13 gene analysis revealed a homozygote of 851del4, and CD was thus confirmed. Diet survey at four years and seven months revealed a fondness for high-protein and low-carbohydrate foods, such as seafood, meat, eggs and milk. This child presented with FTT and dyslipidemia as main clinical manifestations and this was a novel CD phenotype different from NICCD and CTLN2.
authors.affiliation: Department of Pediatrics, First Affiliated Hospital, Jinan University, Guangzhou, China. songyuanzong@tom.com
authors.forename: Yuan-Zong
authors.initials: YZ
authors.lastname: Song
authors.forename: Li
authors.initials: L
authors.lastname: Guo
authors.forename: Yan-Ling
authors.initials: YL
authors.lastname: Yang
authors.forename: Lian-Shu
authors.initials: LS
authors.lastname: Han
authors.forename: Keiko
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Takeyori
authors.initials: T
authors.lastname: Saheki
mesh_terms: D001835:Body Weight; D002135:Calcium-Binding Proteins / Q000172:deficiency*; D002780:Cholestasis, Intrahepatic / Q000209:etiology; D002956:Citrulline / Q000097:blood; D050171:Dyslipidemias / Q000209:etiology*; D005183:Failure to Thrive / Q000209:etiology*; D006801:Humans; D007223:Infant; D008055:Lipids / Q000097:blood; D008297:Male; D033681:Mitochondrial Membrane Transport Proteins / Q000235:genetics; D009154:Mutation; D027361:Organic Anion Transporters / Q000172:deficiency*; D010641:Phenotype
chemical_list: D002135:Calcium-Binding Proteins; D008055:Lipids; D033681:Mitochondrial Membrane Transport Proteins; D027361:Organic Anion Transporters; C119629:SLC25A13 protein, human; C008822:citrin; D002956:Citrulline